These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8080716

  • 1. The accuracy and reproducibility of measuring blood flow in murine tumours by the D2O uptake and clearance techniques.
    Bradley JK, Counsell CJ, Bremner JC, Sansom JM, Adams GE.
    NMR Biomed; 1994 May; 7(3):141-8. PubMed ID: 8080716
    [Abstract] [Full Text] [Related]

  • 2. Deuterium nuclear magnetic resonance imaging of tracer distribution in D2O clearance measurements of tumor blood flow in mice.
    Larcombe McDouall JB, Evelhoch JL.
    Cancer Res; 1990 Jan 15; 50(2):363-9. PubMed ID: 2153050
    [Abstract] [Full Text] [Related]

  • 3. Measurement of relative regional tumor blood flow in mice by deuterium NMR imaging.
    Evelhoch JL, McDouall JB, Mattiello J, Simpson NE.
    Magn Reson Med; 1992 Mar 15; 24(1):42-52. PubMed ID: 1532621
    [Abstract] [Full Text] [Related]

  • 4. Effect of vasoactive drugs on tumour blood flow as determined by 2H nuclear magnetic resonance spectroscopy.
    Burney IA, Maxwell RJ, Field SB, McCoy CL, Griffiths JR.
    Acta Oncol; 1995 Mar 15; 34(3):367-71. PubMed ID: 7779425
    [Abstract] [Full Text] [Related]

  • 5. The combined measurement of blood flow and metabolism in RIF-1 tumours in vivo. A study using H2 flow and 31P NMR spectroscopy.
    Bhujwalla ZM, Tozer GM, Field SB, Proctor E, Busza A, Williams SR.
    NMR Biomed; 1990 Aug 15; 3(4):178-83. PubMed ID: 2206850
    [Abstract] [Full Text] [Related]

  • 6. Relative volume-average murine tumor blood flow measurement via deuterium nuclear magnetic resonance spectroscopy.
    Mattiello J, Evelhoch JL.
    Magn Reson Med; 1991 Apr 15; 18(2):320-34. PubMed ID: 1646371
    [Abstract] [Full Text] [Related]

  • 7. Induction of tumour hypoxia by a vasoactive agent. A combined NMR and radiobiological study.
    Dunn JF, Frostick S, Adams GE, Stratford IJ, Howells N, Hogan G, Radda GK.
    FEBS Lett; 1989 Jun 05; 249(2):343-7. PubMed ID: 2737292
    [Abstract] [Full Text] [Related]

  • 8. Use of fluorine-19 nuclear magnetic resonance spectroscopy and hydralazine for measuring dynamic changes in blood perfusion volume in tumors in mice.
    Thomas C, Counsell C, Wood P, Adams GE.
    J Natl Cancer Inst; 1992 Feb 05; 84(3):174-80. PubMed ID: 1542128
    [Abstract] [Full Text] [Related]

  • 9. In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification.
    Bremner JC, Counsell CJ, Adams GE, Stratford IJ, Wood PJ, Dunn JF, Radda GK.
    Br J Cancer; 1991 Nov 05; 64(5):862-6. PubMed ID: 1931606
    [Abstract] [Full Text] [Related]

  • 10. Quantitative determination of tumor blood flow and perfusion via deuterium nuclear magnetic resonance spectroscopy in mice.
    Kim SG, Ackerman JJ.
    Cancer Res; 1988 Jun 15; 48(12):3449-53. PubMed ID: 2836055
    [Abstract] [Full Text] [Related]

  • 11. Deuterium MR spectroscopy at 4.7 T. Quantification of tumour and subcutaneous tissue blood flow in animal models.
    Wirestam R, Larsen VA, Stubgaard M, Thomsen C, Vikhoff B, Larsson HB, Ståhlberg F, Henriksen O.
    Acta Radiol; 1995 Jan 15; 36(1):85-91. PubMed ID: 7833176
    [Abstract] [Full Text] [Related]

  • 12. Measurement of tumor blood flow by deuterium NMR and the effects of modifiers.
    Evelhoch JL.
    NMR Biomed; 1992 Jan 15; 5(5):290-5. PubMed ID: 1449970
    [Abstract] [Full Text] [Related]

  • 13. Magnetic resonance spectroscopic studies on 'real-time' changes in RIF-1 tumour metabolism and blood flow during and after photodynamic therapy.
    Bremner JC, Bradley JK, Stratford IJ, Adams GE.
    Br J Cancer; 1994 Jun 15; 69(6):1083-7. PubMed ID: 8198974
    [Abstract] [Full Text] [Related]

  • 14. Non-invasive tumour blood perfusion measurement by 2H magnetic resonance.
    Bentzen L, Horsman MR, Daugaard P, Maxwell RJ.
    NMR Biomed; 2000 Dec 15; 13(8):429-37. PubMed ID: 11252028
    [Abstract] [Full Text] [Related]

  • 15. Effects of hydralazine on the blood flow in RIF-1 tumors and normal tissues of mice.
    Lin JC, Song CW.
    Radiat Res; 1990 Nov 15; 124(2):171-7. PubMed ID: 2247597
    [Abstract] [Full Text] [Related]

  • 16. The effect of hydralazine on blood flow and misonidazole toxicity in human tumour xenografts.
    Guichard M, Lespinasse F, Trotter M, Durand R, Chaplin D.
    Radiother Oncol; 1991 Feb 15; 20(2):117-23. PubMed ID: 2031087
    [Abstract] [Full Text] [Related]

  • 17. [Use of fluorine-19 nuclear resonance spectroscopy for the measurement of changes induced in blood perfusion volume in experimental tumors in vivo].
    Thomas C, Counsell C, Wood P, Adams G.
    Bull Cancer; 1993 Aug 15; 80(8):666-73. PubMed ID: 7515732
    [Abstract] [Full Text] [Related]

  • 18. Changes in perfusion of mouse tumours after photodynamic therapy.
    van Geel IP, Oppelaar H, Oussoren YG, Stewart FA.
    Int J Cancer; 1994 Jan 15; 56(2):224-8. PubMed ID: 8314306
    [Abstract] [Full Text] [Related]

  • 19. Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours.
    Horsman MR, Nordsmark M, Høyer M, Overgaard J.
    Br J Cancer; 1995 Dec 15; 72(6):1474-8. PubMed ID: 8519662
    [Abstract] [Full Text] [Related]

  • 20. 31P magnetic resonance spectroscopy as a predictor of efficacy in photodynamic therapy using differently charged zinc phthalocyanines.
    Bremner JC, Wood SR, Bradley JK, Griffiths J, Adams GE, Brown SB.
    Br J Cancer; 1999 Oct 15; 81(4):616-21. PubMed ID: 10574246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.